- Reported transaction lines
- 3
- Buy lines
- 1
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-113
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Zhang Ingrid Chief Executive Officer · Legend Biotech Corp | LEGN Legend Biotech Corp | BuyFiling detailsSEC transaction code P Ordinary Shares · Direct ownership · Reported balance after transaction: 1151860 · SEC code covers open-market or private transactions · The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. · The price reported in Column 4 represents the converted purchase price of the ADSs of $16.32 per ADS. | 2026-11-17 | 2026-11-20 | ≈ $163,200.00 20,000 shares/units | SEC 4 |
| Zhang Ingrid Director · METTLER TOLEDO INTERNATIONAL INC/ | MTD METTLER TOLEDO INTERNATIONAL INC/ | Equity grant or awardFiling detailsSEC transaction code A Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 130 · The options vest annually in two equal installments beginning on the first anniversary of the date of grant. | 2026-11-10 | 2026-11-12 | 130 shares/units | SEC 4 |
| Zhang Ingrid Director · METTLER TOLEDO INTERNATIONAL INC/ | MTD METTLER TOLEDO INTERNATIONAL INC/ | Equity grant or awardFiling detailsSEC transaction code A Common Stock, par value $0.01 per share · Direct ownership · Reported balance after transaction: 261 | 2026-11-10 | 2026-11-12 | 54 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.